Back to MENORA MIVTACHIM HOLDINGS LTD. MENORA MIVTACHIM HOLDINGS LTD.

URGNURGN
30 quarters

Position history for MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.'s holdings in UROGEN PHARMA LTD

MENORA MIVTACHIM HOLDINGS LTD. holds 1.2M shares of URGN (UROGEN PHARMA LTD), worth $42.4M as of 2026-Q2. URGN represents 0.2% of MENORA MIVTACHIM HOLDINGS LTD.'s portfolio.

Current Value

$42.4M

Current Shares

1.2M

Total Value Change

-$66.7M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.2M
0.0%
$42.4M0.2%$36.80
0
2026-Q1
Unchanged
1.2M
0.0%
$20.7M0.1%$18.82
0
2025-Q4
Unchanged
1.2M
0.0%
$27M0.1%$23.17
0
2025-Q3
Unchanged
1.2M
0.0%
$23M0.1%$19.14
0
2025-Q2
Decreased
1.2M
-50.0%
$15.8M0.1%$13.49
0
2025-Q1
Unchanged
2.3M
0.0%
$25.5M0.2%$11.20
0
2024-Q4
Unchanged
2.3M
0.0%
$24.5M0.2%$10.52
0
2024-Q3
Unchanged
2.3M
0.0%
$29.2M0.2%$12.90
0
2024-Q2
Unchanged
2.3M
0.0%
$38.6M0.3%$16.78
0
2024-Q1
Unchanged
2.3M
0.0%
$34.5M0.3%$15.00
0
2023-Q4
Unchanged
2.3M
0.0%
$34.5M0.3%$15.00
0
2023-Q3
Decreased
2.3M
-9.0%
$32.3M0.3%$14.01
0
2023-Q2
Decreased
2.5M
-13.3%
$26.2M0.2%$10.74
0
2023-Q1
Unchanged
2.9M
0.0%
$27M0.3%$8.38
0
2022-Q4
Unchanged
2.9M
0.0%
$25.9M0.4%$8.87
0
2022-Q3
Decreased
2.9M
-1.0%
$24.3M0.5%$8.22
0
2022-Q2
Decreased
2.9M
-0.1%
$24.2M0.4%$7.81
0
2022-Q1
Unchanged
3M
0.0%
$25.7M0.4%$9.07
0
2021-Q4
Decreased
3M
-0.1%
$28.1M0.4%$9.90
0
2021-Q3
Unchanged
3M
0.0%
$49.7M0.7%$17.01
0
2021-Q2
Unchanged
3M
0.0%
$45.1M0.6%$15.94
0
2021-Q1
Unchanged
3M
0.0%
$57.6M0.9%$18.52
0
2020-Q4
Unchanged
3M
0.0%
$53.2M0.9%$18.09
0
2020-Q3
Unchanged
3M
0.0%
$57M1.3%$19.32
0
2020-Q2
Unchanged
3M
0.0%
$77.2M1.9%$25.45
0
2020-Q1
Unchanged
3M
0.0%
$52.7M1.4%$18.16
0
2019-Q4
Unchanged
3M
0.0%
$98.6M2.4%$33.99
0
2019-Q3
Unchanged
3M
0.0%
$70.4M1.7%$23.98
0
2019-Q2
Unchanged
3M
0.0%
$106.2M2.9%$35.94
0
2019-Q1
New
3M
-
$109.1M2.9%$36.94
78

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used